Advertisement

Topics

Aratana Therapeutics to Report Third Quarter 2016 Financial Results

04:48 EDT 19 Oct 2016 | PR Newswire
This article has expired, however you can still download the PDF.
Preview:
LEAWOOD, Kan., Oct. 19, 2016 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals, will host a ...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Aratana Therapeutics to Report Third Quarter 2016 Financial Results"

Quick Search
Advertisement
 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...